Joinn Laboratories (06127) cancelled 12.91 million shares of inventory stock on January 7th.
Zhao Yan New Drug (06127) announced that on January 7, 2026, it cancelled 129,100 shares of stock previously designated for the 2021 and 2022 A-share employee stock ownership plans.
Joinn Laboratories (06127) announced that on January 7, 2026, it will cancel 129,100 shares of common stock related to the 2021 and 2022 A-share employee stock ownership plans.
Related Articles

Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.

Industrial: Hong Kong stock market sentiment index has reached the bottom area.

"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"

RECOMMEND

Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026

Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026

Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026


